We are live on ! Find out more
S

swisspartners Portfolio holdings

AUM $78.4M
1-Year Est. Return 9.82%
This Fund
S&P 500
This Quarter Est. Return
-18.17%
1 Year Est. Return
-9.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105M
AUM Growth
-$21.8M
Cap. Flow
-$692K
Cap. Flow %
-0.66%
Top 10 Hldgs %
51.44%
Holding
88
New
7
Increased
14
Reduced
11
Closed
10

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$2.36M
2
RL icon
Ralph Lauren
RL
+$1.21M
3
ALK icon
Alaska Air
ALK
+$1.17M
4
MPC icon
Marathon Petroleum
MPC
+$841K
5
SBSW icon
Sibanye-Stillwater
SBSW
+$314K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.45M
2
PBR icon
Petrobras
PBR
+$2.17M
3
TSM icon
TSMC
TSM
+$1.26M
4
PLL
Piedmont Lithium
PLL
+$730K
5
NFLX icon
Netflix
NFLX
+$273K

Sector Composition

Rank Sector Weight
1 Technology 22.58%
2 Consumer Discretionary 18.85%
3 Financials 18.69%
4 Communication Services 8.3%
5 Industrials 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
26
Alphabet (Google) Class C
GOOG
$4.22T
$1.05M 1%
9,280
+200
+2% +$23.6K
FTI icon
27
TechnipFMC
FTI
$28.7B
$1.04M 1%
150,000
– –
MRNA icon
28
Moderna
MRNA
$24.5B
$1.02M 0.97%
6,900
-1,750
-20% -$250K
UBS icon
29
UBS Group
UBS
$173B
$1.01M 0.96%
60,528
– –
ALK icon
30
Alaska Air
ALK
$5.07B
$992K 0.95%
+24,000
New +$1.17M
UPS icon
31
United Parcel Service
UPS
$100B
$867K 0.83%
4,600
– –
RCL icon
32
Royal Caribbean
RCL
$77B
$863K 0.82%
23,940
– –
BKNG icon
33
Booking.com
BKNG
$141B
$794K 0.76%
11,000
+1,375
+14% +$117K
BBBY
34
Bed Bath & Beyond
BBBY
$479M
$775K 0.74%
33,000
– –
MPC icon
35
Marathon Petroleum
MPC
$91.3B
$764K 0.73%
+9,000
New +$841K
JNJ icon
36
Johnson & Johnson
JNJ
$609B
$742K 0.71%
4,050
– –
ALC icon
37
Alcon
ALC
$34.3B
$678K 0.65%
9,404
-200
-2% -$14.6K
FCX icon
38
Freeport-McMoran
FCX
$83.9B
$668K 0.64%
22,118
– –
FDX icon
39
FedEx
FDX
$74.7B
$632K 0.6%
2,700
– –
MA icon
40
Mastercard
MA
$480B
$628K 0.6%
1,927
– –
BNTX icon
41
BioNTech
BNTX
$23.1B
$597K 0.57%
3,880
+100
+3% +$15.3K
QGEN icon
42
Qiagen
QGEN
$8.49B
$581K 0.56%
11,317
– –
MDT icon
43
Medtronic
MDT
$106B
$553K 0.53%
5,965
– –
ZTS icon
44
Zoetis
ZTS
$32.1B
$545K 0.52%
3,070
– –
BABA icon
45
Alibaba
BABA
$276B
$498K 0.48%
4,245
– –
BIDU icon
46
Baidu
BIDU
$36.5B
$461K 0.44%
3,000
-60
-2% -$7.93K
FAT
47
DELISTED
FAT Brands
FAT
$423K 0.4%
98,670
– –
UNH icon
48
UnitedHealth
UNH
$387B
$419K 0.4%
790
+70
+10% +$35.2K
MRK icon
49
Merck
MRK
$315B
$413K 0.39%
4,390
-700
-14% -$62.1K
OTIS icon
50
Otis Worldwide
OTIS
$28.2B
$408K 0.39%
5,593
– –
1
2
3 4

Similar funds

PAM
Premier Asset Management Chicago, Illinois $79.6M AUM 10.77% 1-Year Est. Return
CFS
Capital Financial Services Clifton Park, New York $72.5M AUM 12.95% 1-Year Est. Return
CLCM
Crawford Lake Capital Management Lakewood, New Jersey $87.4M AUM 30.13% 1-Year Est. Return
SGMPI
Spark Growth Management Partners II Boston, Massachusetts $66.6M AUM 51.19% 1-Year Est. Return
BO
block.one George Town, Grand Cayman, Cayman Islands $90.7M AUM
BC
Breakline Capital New York $91.1M AUM 21.05% 1-Year Est. Return
LCH
Lee Capital Holdings New York $65.4M AUM 20.44% 1-Year Est. Return
SCFS
S.C. Financial Services Scottsdale, Arizona $65M AUM 9.66% 1-Year Est. Return

swisspartners's Q2 2022 Portfolio in Review

As of Q2 2022, swisspartners held 88 positions worth $105M, down 17% from $126M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

swisspartners's Q2 2022 filing shows 7 new, 14 increased, 11 reduced and 10 closed positions. Its largest new stake was Ralph Lauren: 12,000 shares worth $1.11M. The largest sale was Bristol-Myers Squibb, an estimated $2.45M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • swisspartners's largest Q2 2022 buy was Ralph Lauren: 12,000 shares worth $1.11M.
  • swisspartners added most to Berkshire Hathaway Class A in Q2 2022, an estimated $2.36M increase.
  • swisspartners's biggest Q2 2022 reduction was Moderna, cutting an estimated $250K.
  • swisspartners fully exited Bristol-Myers Squibb in Q2 2022, selling an estimated $2.45M.
  • swisspartners's ten largest holdings make up 51% of its $105M portfolio in Q2 2022.
  • swisspartners opened 7 new positions and closed 10 in Q2 2022.
  • swisspartners's portfolio value fell 17% quarter-over-quarter to $105M.

Based on swisspartners's 13F filing for Q2 2022, filed 10 Aug 2022.